VIDEO OF THE WEEK: Pros and Cons of Transcatheter Aortic Valve Implantation

Many answers need to be addressed before transcatheter aortic valve implantation (TAVI) is adopted in lower risk patients. This paper highlights the pros and cons of TAVI based mostly on randomized clinical trials involving the two device platforms approved in the United States. The authors focused their analysis on metrics that will play a key role in expanding TAVR indication in healthier individuals. They review the significance and give a perspective on paravalvular leak (PVL), valve performance, valve durability, leaflet thrombosis, stroke and pacemaker requirement.